Enantioselective construction of a polyhydroxylated pyrrolidine skeleton from 3-vinylaziridine-2-carboxylates: Synthesis of (+)-DMDP and a potential common intermediate for (+)-hyacinthacine A1 and (+)-1-epi-australine

Article abstract of DOI:10.1021/jo301178b

We report an enantioselective synthesis of the polyhydroxylated pyrrolidine alkaloid (+)-DMDP. The key steps in the synthesis were guanidinium ylide mediated asymmetric aziridination, stereospecific ring opening of trans-3-vinylaziridine-2- carboxylate with an oxygen nucleophile, iodine-mediated 5-endo-trig amino cyclization, and Prevost displacement. In addition, a potential common intermediate for the polyhydroxylated pyrrolizidine alkaloids (+)-hyacinthacine A1 and (+)-1-epi-australine was synthesized from a diastereoisomeric cis-aziridine coformed in the asymmetric aziridination using the same strategy. A rationale for the diastereoselectivity observed for the iodine-mediated amino cyclization reactions is proposed on the basis of the heats of formation of the products.

Full text of DOI:10.1021/jo301178b

Article
pubs.acs.org/joc
Enantioselective Construction of a Polyhydroxylated Pyrrolidine
Skeleton from 3‑Vinylaziridine-2-carboxylates: Synthesis of
(+)-DMDP and a Potential Common Intermediate for
(+)-Hyacinthacine A1 and (+)-1-epi-Australine
Yukari Kondo,† Noriyuki Suzuki,† Masato Takahashi,† Takuya Kumamoto,† Hyuma Masu,‡
and Tsutomu Ishikawa*,†
†Graduate School of Pharmaceutical Sciences, Chiba University, 1-8-1 Inohana, Chuo, Chiba 260-8675, Japan
‡Chemical Analysis Center, Chiba University, 1-33 Yayoi, Inage, Chiba 263-8522, Japan
S
* Supporting Information
ABSTRACT: We report an enantioselective synthesis of the polyhydroxylated pyrrolidine alkaloid (+)-DMDP. The key steps in
the synthesis were guanidinium ylide mediated asymmetric aziridination, stereospecific ring opening of trans-3-vinylaziridine-2-
carboxylate with an oxygen nucleophile, iodine-mediated 5-endo-trig amino cyclization, and Prevost displacement. In addition, a
́
potential common intermediate for the polyhydroxylated pyrrolizidine alkaloids (+)-hyacinthacine A1 and (+)-1-epi-australine
was synthesized from a diastereoisomeric cis-aziridine coformed in the asymmetric aziridination using the same strategy. A
rationale for the diastereoselectivity observed for the iodine-mediated amino cyclization reactions is proposed on the basis of the
heats of formation of the products.
an enzymatic resolution step has also been reported.9 The
INTRODUCTION
■
asymmetric syntheses of (+)-hyacinthacine A1 (2)10 and (+)-1-
epi-australine (3)11 have been reported, although only three of
the synthetic strategies did not use a sugar. The asymmetric
induction step for the syntheses of (+)-hyacinthacine A1 (2)
has been achieved by the [2 + 2] cycloaddition of
dichloroketene to an enol ether containing (S)-(−)-Stericol
as a chiral auxiliary.12 In the case of (+)-1-epi-australine (3),
sequential intramolecular [4 + 2] and intermolecular [3 + 2]
nitroalkene cycloadditions13 and Sharpless dihydroxylation of
pyrrolo[1,2-c]oxazol-3-one11 were used as the asymmetric
induction step, respectively.
Polyhydroxylated pyrrolidine and pyrrolizidine alkaloids, which
contain a common 5-substituted 3,4-dihydroxy-2-
(hydroxymethyl)pyrrolidine core, have attracted much atten-
tion because of their interesting biological activity, such as the
strong inhibition of a range of glucosidases.1 These alkaloids
have been the synthetic target of many studies, despite their
relatively simple structures, owing to the presence of the
2,3,4,5-tetrasubstituted pyrrolidine skeleton with four stereo-
genic centers.2 (+)-DMDP (1) was first isolated from Derris
elliptica (Leguminosae; Papilionitae) in 1976,3 and its structure
was subsequently determined as C2-symmetric (2R,3R,4R,5R)-
3,4-dihydroxy-2,5-bis(hydroxymethyl)pyrrolidine by X-ray anal-
ysis.4 (+)-Hyacinthacine A1 (2) and (+)-1-epi-australine (3)
were first isolated from Muscari armeniacum (Hyacinthaceae) in
20005 and Castanospermum australe (Leguminosae) in 1989,6
respectively. They are classified as polyhydroxylated pyrrolizi-
dine alkaloids, which contain a common 5-substituted
(2R,3R,4S,5R)-3,4-dihydroxy-2-(hydroxymethyl)pyrrolidine
core.
We have developed a unique method for forming aziridines
by the reaction of guanidinium ylide with an aromatic or
unsaturated aldehyde, which can be used in asymmetric
synthesis.14 We have also examined the ring-opening reaction
of unactivated 3-aryl or unsaturated aziridine-2-carboxylates
formed by using various nucleophiles.14c,e,15 In this paper we
report the enantioselective synthesis of (+)-DMDP (1) and a
potential common intermediate for (+)-hyacinthacine A1 (2)
and (+)-1-epi-australine (3). The key steps in the synthesis
were guanidinium ylide mediated asymmetric aziridination,
More than 20 groups7 have achieved the asymmetric
synthesis of DMDP. Although the majority of these syntheses
used a sugar as a chiral source, Trost et al. used a dynamic
kinetic asymmetric transformation in the asymmetric allylic
alkylation of butadiene monoepoxide,8 and an approach using
Received: June 15, 2012
© XXXX American Chemical Society
A
dx.doi.org/10.1021/jo301178b | J. Org. Chem. XXXX, XXX, XXX−XXX

The Journal of Organic Chemistry
Article
Scheme 1. Retrosynthetic Analysis
stereospecific ring opening of diastereoisomeric 3-vinylazir-
idine-2-carboxylates with an oxygen (O-) nucleophile, iodine-
as a base followed by treatment with acetic anhydride according
to our protocol14 provided trans-3-vinylaziridine-2-carboxylate
(trans-8) in 31% yield (77% ee as the 2S,3R configuration) and
the cis isomer (cis-8) in 33% yield (85% ee as the 2S,3S
configuration) (Scheme 2).
mediated 5-endo-trig amino cyclization, and Prev
́
ost displace-
ment.
RESULTS AND DISCUSSION
■
Scheme 2. Asymmetric Aziridination
Our retrosynthetic analysis is shown in Scheme 1. The (2S,3R)-
trans- and (2S,3S)-cis-3-vinylaziridine-2-carboxylates can be
obtained by aziridination of 4-oxybut-2-enal with (R,R)-
guanidinium bromide (4) and would produce the anti- and
syn-2-amino-3,6-dioxyhex-4-enoates, respectively, through the
regioselective and stereospecific ring-opening reaction with an
O-nucleophile.14c,e The iodine-catalyzed 5-endo-trig cyclization
of these amino esters should afford 4-iodoprolinates,16 and the
2,3-trans-3,4-trans-4,5-trans derivative could be used to access
(+)-DMDP (1) after chemical manipulation of the iodine atom
and the ester functional group. The corresponding 2,3-cis-3,4-
cis-4,5-trans-4-iodoprolinate could function in a way similar to
that for the prolinal (5) reported by Donohoe et al., which has
been converted into ( )-hyacinthacine A1 (( )-2) and ( )-1-
epi-australine (( )-3).17
The (E)-4-(tert-butyldimethylsilyloxy)but-2-enal (7) starting
material for the aziridination was prepared by partial protection
of commercially available (Z)-1,4-dihydroxybut-2-ene (6) with
tert-butyldimethylsilyl chloride (TBSCl; 93%) and then by
oxidative isomerization with pyridinium chlorochromate (PCC;
82%).18 Treatment of butenal 7 with (R,R)-guanidinium
bromide 4 in the presence of tetramethylguanidine (TMG)
Invertomers at the aziridine nitrogen were observed for the
trans-aziridine (trans-8) at a ratio of 1.2:1 by 1H NMR
spectroscopy (Figure 1).
Synthesis of (+)-DMDP (1). Initially, the synthesis of
(+)-DMDP (1) was attempted. The trans-aziridine (trans-8)
underwent a ring-opening reaction upon treatment with an O-
nucleophile, providing a 4,5-unsaturated 2-amino ester
B
dx.doi.org/10.1021/jo301178b | J. Org. Chem. XXXX, XXX, XXX−XXX

The Journal of Organic Chemistry
Article
Figure 1. Invertomers of trans-aziridine (trans-8).
substrate for intramolecular cyclization. The treatment of trans-
8 with acetic acid exclusively provided anti-tert-butyl 3-acetoxy-
2-benzylamino-6-(tert-butyldimethylsilyloxy)hex-4-enoate
(anti-9) in 91% yield. The coupling constant between the C2
and C3 protons (J = 5.5 Hz) indicated that the 2,3-
stereochemistry was anti.14c When trans-8 was treated with
water in the presence of p-toluenesulfonic acid hydrate
(TsOH·H2O), the same anti-amino ester (anti-10) was
obtained in 84% yield as a single product, even though
desilylation occurred.
Figure 2. NOE enhancements in 3,4-cis-3-hydroxy-4-iodoprolinates:
(a) the minor diastereoisomer 14 derived from anti-10; (b) the major
diastereoisomer 25 derived from syn-10.
with those of the corresponding N-deprotected derivatives
(13a, −184.4 kcal/mol; 14a, −180.7 kcal/mol) (Figure 3a).
Therefore, each transition state (TS) was examined to explain
the observed diastereoselectivity.
Treatment of anti-9 in ethyl acetate with iodine in the
presence of potassium carbonate (K2CO3) at −40 °C for 1 h
provided the 5-endo-trig cyclization products in 83% yield. The
reaction produced a diastereoisomeric mixture of 2,3-trans-3,4-
trans-4,5-trans-3-acetoxy-4-iodoprolinate 11 and the 2,3-trans-
1
3,4-cis-4,5-trans one 12 in a 9:1 ratio, as determined by H
NMR. In the reaction of anti-10, the cyclized products were
chromatographically separable, which allowed the isolation of
3,4-trans-3-hydroxy-4-iodoprolinate 13 and its 3,4-cis diaster-
eoisomer 14 in 62% and 13% yields, respectively (Scheme 3).
The stereochemistry of the diastereoisomers derived from
anti-10 was deduced from NOE enhancements between the C3
and C4 protons in the minor diastereoisomer 14 (Figure 2a).
The selectivity of the iodoamination reaction was not improved
when dichloromethane (CH2Cl2) or tetrahydrofuran (THF)
was used instead of ethyl acetate.
The heat of formation of the N-benzyl-3-hydroxy-4-
iodoprolinates derived from anti-10 was calculated by
MOPAC, a semiempirical molecular orbital program. This
showed that the major diastereoisomer 13 (−153.0 kcal/mol)
was slightly less stable than the minor isomer 14 (−154.0 kcal/
mol), and the predicted stability of all-trans-13a was compared
Figure 3. Heat of formation of tert-butyl 1-benzyl-3-hydroxy-5-
hydroxymethyl-4-iodoprolinates and their N-deprotected derivatives:
(a) derivatives from anti-10; (b) derivatives from syn-10.
TS-1 produces the 3,4-trans derivatives (11, 13), whereas
TS-2 produces the 3,4-cis derivatives (12, 14). In TS-2, two
bulky substituents at the C2 (CO2 Bu) and C5 (CH2OR1)
t
Scheme 3. Ring-Opening Reaction
C
dx.doi.org/10.1021/jo301178b | J. Org. Chem. XXXX, XXX, XXX−XXX

The Journal of Organic Chemistry
Article
positions (pyrrolidine system numbering) are close to each
other. This could explain the preferred formation of all-trans
pyrrolidines 11 and 13 during the intramolecular iodoamina-
tion of anti-9 and -10 (Scheme 4). The product distribution
gave 3,4-trans-3,4-diacetoxyprolinate 16 with retention of the
substituent at the C4 position (Scheme 6).
The reduction of diacetoxyprolinate 16 with lithium
borohydride, followed by the deprotection of the TBS group,
provided C2-symmetric (−)-N-benzyl (Bn)-DMDP 19 as a
crystalline product ([α]D = −14.2°). An optically pure
(+)-enantiomer (ent-19) ([α]D = +20°) has been synthesized
by Colobert et al.19 The recrystallization of 19 from
chloroform/acetone/hexane (5/1/0.1) afforded an optically
pure (−)-product ([α]D = −20.8°). However, a discrepancy
was found in the assignment of the coupling constant of the
Scheme 4. Rationale for Diastereoselectivity in Iodination
1
double doublet for the C3 and C4 protons in the H NMR
spectrum. In the literature19 the coupling constants were
reported as J3,4 = 8.6 and 2.7 Hz, whereas we measured
coupling constants of J3,4 = 2.4 and 1.1 Hz. Therefore, we
examined the X-ray crystallographic structure of 19 and
unambiguously established its stereochemistry to be
2R,3R,4R,5R (see the ORTEP drawing in Scheme 7).20 Finally,
the N-Bn group on 19 was removed by catalytic hydrogenation
and the product was purified using an ion-exchange resin to
afford (+)-DMDP (1) in 71% yield.
This synthetic approach can be applied to the synthesis of
(+)-casuarine (21) because 3,4-trans-3,4-dibenzyloxy-5-[(tert-
butyldimethylsilyloxy)methyl]prolinate 20, which was reported
as a key synthetic precursor by Izquierdo et al.,21 may be
derived from diacetoxyprolinate 16 by applying our reaction
conditions of basic hydrolysis (see 29 → 30 in Scheme 12) and
deprotection of the N-benzyl group by catalytic hydrogenation
(see 19 → 1 in Scheme 7) (Scheme 8).
from the transition states has been discussed by Knight et al. in
relation to the iodoamination of homoallylic sulfonamides16d,e
and in the synthesis of anisomycin by Park et al.16b
The conversion of the iodoprolinate to the corresponding
hydroxy derivative through epoxide formation was examined
first. Treatment of 3,4-trans-3-hydroxy-4-iodoprolinate (13)
with K2CO3 in methanol (MeOH) smoothly afforded epoxide
15. However, the acid-catalyzed ring-opening reaction with O-
nucleophiles failed (Scheme 5).
Synthesis of a Potential Common Intermediate for
(+)-Hyacinthacine A1 (2) and (+)-1-epi-Australine (3).
Donohoe et al. reported the syntheses of ( )-hyacinthacine A1
(( )-2) and ( )-1-epi-australine (( )-3) starting from N-tert-
butoxycarbonyl (Boc)-2,5-bis(methoxycarbonyl)pyrrole via N-
Boc-5-[(tert-butyldimethylsilyloxy)methyl]-3,4-dihydroxyproli-
nal dimethylacetal (( )-5) as a common synthetic intermedi-
ate.17 Thus, we attempted the preparation of the optically active
prolinal (5) reported by Donohoe et al. as a potential common
intermediate for (+)-hyacinthacine A1 (2) and (+)-1-epi-
australine (3). Prolinal 5 was obtained from cis-aziridine-2-
carboxylate (cis-8), which was produced by the diastereoiso-
meric asymmetric aziridination as shown in Scheme 2, using the
same strategy as for the synthesis of (+)-DMDP (1).
Scheme 5. Attempts to Incorporate O Functionality
́
Therefore, we used a Prevost displacement with neighboring
group participation.16b,c The treatment of 3-acetoxy-4-iodopro-
linate 11 (92% de) with silver acetate (AcOAg) in acetic acid
(AcOH) at 40 °C for 15 h gave the desired 3,4-trans-3,4-
diacetoxyprolinate 16 in 57% yield as a single diastereoisomer.
The coformation of aromatized pyrrole derivative 17 as a
byproduct (26%) was observed. A double SN2 substitution
through the neighboring group participation of the 3-acetoxy
function in 11, followed by the nucleophilic attack of an
alternative acetoxy function at the less hindered C4 position,
The stereospecific ring-opening reaction of the cis-aziridine
cis-8 with O-nucleophiles afforded the syn products syn-9 and
-10. Product syn-10, which was more easily crystallized than
syn-9, was optically purified up to 99% ee from 85% ee by
recrystallization from hexane/ethyl acetate (10/1) (Scheme 9).
Scheme 6. Prevost Displacement
́
D
dx.doi.org/10.1021/jo301178b | J. Org. Chem. XXXX, XXX, XXX−XXX

The Journal of Organic Chemistry
Article
Scheme 7. Synthesis of (+)-DMDP (1)
C2 and C3 protons (J = 4.4 Hz in syn-9),14c and the 3,4-cis
configuration of the major diastereoisomers 22 and 25 in the
iodoamination was assigned from the NOE enhancement
between the C3 and C4 protons on 25 derived from syn-10
(Figure 2b).
Scheme 8. Possible Conversion to (+)-Casuarine (21)
The calculation of the heat of formation of 3-hydroxy-4-
iodoprolinates 25 (−150.1 kcal/mol) and 26 (−156.5 kcal/
mol) derived from syn-10 (Figure 3b) predicted diastereose-
lectivity opposite to that observed in the iodoamination of syn-9
and -10. The same rationale for the transition states in Scheme
4 could be applied to the preferential formation of the 3,4-cis-
pyrrolidines 22 and 25 to the 3,4-trans-pyrrolidines 23 and 26
(Scheme 10). In TS-4, which produces the 3,4-trans derivatives
In the subsequent iodoamination, the 5-endo-trig cyclization
provided the 2,3-cis-3,4-cis-3-acetoxy-4-iodoprolinate 22 from
syn-9 and the corresponding 3-hydroxy derivative 25 from syn-
10 as major products, respectively. Interestingly, better
diastereoselectivity than for the anti derivatives was obtained
in these cyclizations (see Scheme 3). Partial aromatization was
observed during the trial purification of 2,3-cis-3-acetoxy-4-
iodoprolinates 22 and 23 by silica gel column chromatography,
which produced pyrrole derivative 24. However, 2,3-cis-3,4-cis-
3-hydroxy-4-iodoprolinate 25 was successfully isolated in 90%
yield when syn-10 was cyclized.
t
23 and 26, steric hindrance could arise between the 2-CO2 Bu
and the 5-CH2OR1 groups, whereas there is no steric hindrance
in TS-3. This results in the major 3,4-cis diastereoisomers 22
and 25.
Here it is worthwhile to discuss the relative stability of the
iodoamination products from anti- and syn-alcohols 10 on the
basis of their heats of formation (Figure 3). As expected, all-
trans 13a was calculated to be the most stable prolinate in the
The stereochemistry of the ring-opened products syn-9 and
-10 was assigned based on the coupling constant between the
Scheme 9. Ring-Opening Reaction and Iodoamination
E
dx.doi.org/10.1021/jo301178b | J. Org. Chem. XXXX, XXX, XXX−XXX

The Journal of Organic Chemistry
Article
protection of the primary hydroxyl group in triol 30 with
TBSCl, the 3,4-dihydroxy functions were acetalized with 2,2-
dimethoxypropane. The nitrogen substituent in acetal 32 was
changed from a Bn to a Boc group by catalytic hydrogenation
in the presence of (Boc)2O, which afforded the N-Boc acetal
33. Treatment of 33 with lithium borohydride provided alcohol
34 in 79% yield, which was then oxidized with Dess−Martin
periodinane (DMP) without further purification to afford
aldehyde 5 as a crystalline (−)-derivative (mp 65−69 °C;
Scheme 10. Rationale for Diastereoselectivity in
Iodoamination
24
[α]D = −145.3°) in an overall yield of 26% from triol 30
(Scheme 12). The data for prolinal 5 were identical with those
reported by Donohoe et al. for the intermediate of
( )-hyacinthacine A1 (( )-2) and ( )-1-epi-australine
(( )-3)17 except for the optical rotation. Trials for the direct
conversion of the tert-butyl ester in N-Boc acetal 33 to an
aldehyde group using diisobutylaluminum hydride as a
reductant resulted in a poor yield of prolinal 5 (18%; 22%
based on recovered starting material) and the coproduction of
an over-reduced 34.
N-deprotected prolinate series. Furthermore, the order of
stability was 13a > 26a > 14a > 25a, which suggests that the cis
relationship between the 3-hydroxy group and the 4-iodine
atom in 14a and 25a (ΔH13a‑14a = 3.7 kcal/mol and ΔH26a‑25a
=
5.0 kcal/mol) caused more severe steric repulsion than the cis
relationship between the 2-ester and 3-hydroxy groups in 25a
and 26a (ΔH14a‑25a = 2.4 kcal/mol and ΔH13a‑26a = 2.1 kcal/
mol). In contrast, the stability order of the N-benzyl prolinates
was 26 > 14 > 13 > 25. In particular, the lower stability of all-
trans derivative 13 could be attributed to the steric repulsion
introduced between the benzyl substituent on the ring nitrogen
atom and either the 2-ester or the 5-hydroxymethyl groups
(Figure 4). This destabilization effect caused by the N-
substitution may also be supported by comparing the energy
difference between the 2,5-cis and 2,5-trans derivatives. Larger
differences were calculated in the N-benzyl prolinates than in
the corresponding N-deprotected ones: ΔH26‑13 = 3.5 kcal/mol
CONCLUSION
■
We have successfully achieved the enantioselective synthesis of
(+)-DMDP, a typical polyhydroxylated pyrrolidine alkaloid.
The key steps in the synthesis were guanidinium ylide mediated
asymmetric aziridination, stereospecific ring opening of trans-3-
vinylaziridine-2-carboxylate with an O-nucleophile, iodine-
́
mediated 5-endo-trig amino cyclization, and Prevost displace-
ment. Using the same strategy, we also synthesized a potential
common intermediate for polyhydroxylated pyrrolizidine
alkaloids (+)-hyacinthacine A1 and (+)-1-epi-australine from a
diastereoisomeric cis-aziridine coformed during the asymmetric
aziridination. It was suggested that product distribution in the
iodine-mediated amino cyclization reaction was controlled by
both the C2 stereogenic center and the configuration of the
double bond in the tert-butyl 2-benzylamino-3,6-dioxyhexa-4-
enoate starting material.
vs ΔH13a‑26a = 2.1 kcal/mol in the 3,4-trans series and ΔH14‑25
=
3.9 kcal/mol vs ΔH14a‑25a = 2.4 kcal/mol in the 3,4-cis series.
To displace the iodine atom in 4-iodoprolinates 22 and 25
with an oxygen functional group and retain the stereochemistry,
́
we intended to exploit Prevost neighboring group participation
EXPERIMENTAL SECTION
of the primary acetoxy group on the 5-substituent. In cyclic
intermediate 27, two electrophilic carbons (4-CH and 5′-CH2)
are present. We predicted that the 4-methine carbon should be
more easily attacked by an acetoxy anion than the 5′-methylene
carbon, because of the potential carbocationic character, even
though it is more sterically crowded (Scheme 11).
■
Melting points were determined with a melting point hot-stage
instrument and are uncorrected. 1H and 13C NMR spectra were
recorded with 400 and 600 MHz spectrometers in CDCl3 unless
otherwise stated. FAB and ESI mass spectra were obtained using a
double-focusing magnetic sector mass spectrometer and time-of-flight
mass spectrometer, respectively. For column and flash chromatog-
raphy silica gel 60 (63−210 and 40−100 μm, respectively) was used.
The organic extracts were dried over MgSO4, and evaporations were
done under reduced pressure.
Following the selective acetylation of the primary alcoholic
function in 3-hydroxy-5-hydroxymethyl-4-iodoprolinate (25),
monoacetate 28 was treated with AcOAg in a mixture of AcOH
and CH2Cl2 to provide diacetate 29 in 59% yield. Diacetate 29
was obtained as an inseparable regioisomeric mixture of the 3-
and 4-acetoxy derivatives and was chemically identified after
conversion into a single triol (30) by methanolysis. Displace-
ment of the iodine atom in 3-hydroxy-4-iodoprolinate 28 with
an O-functional group with stereochemical retention was
confirmed by X-ray crystallographic analysis of triol 30 (see
the ORTEP drawing in Scheme 12).20 After the selective
Preparation of Guanidinium Bromide 4. (4R,5R)-2-[(tert-
Butoxycarbonyl)methyl]imino-1,3-dimethyl-4,5-diphenylimidazoli-
dine.14a A mixture of (4R,5R)-1,3-dimethyl-4,5-(diphenyl)-
imidazolidin-2-one22 (3.93 g, 14.8 mmol) and oxalyl chloride (6.5
mL, 74.5 mmol) in dry benzene (40 mL) was stirred at 80 °C for 9 h
under Ar and evaporated to give 2-chloroimidazolium chloride (4.64 g,
1
88% purity by H NMR) as colorless solids. After the whole crude
chloride was dissolved in dry CH2Cl2 (30 mL), triethylamine (6.5 mL,
47.2 mmol) and a mixture of tert-butyl glycinate hydrochloride (1.59 g,
Figure 4. Effect of the introduction of an N-benzyl protecting group on the stability of all-trans-3-hydroxy-5-hydroxymethyl-4-iodoprolinate (13a).
F
dx.doi.org/10.1021/jo301178b | J. Org. Chem. XXXX, XXX, XXX−XXX

The Journal of Organic Chemistry
Article
Scheme 11. Possible Cyclic Intermediate
Scheme 12. Asymmetric Synthesis of Prolinal 5
9.51 mmol) in dry CH2Cl2 (9 mL) were successively added with ice
cooling under an Ar atomsphere. The resulting mixture was stirred at
room temperature (rt) for 3 h and evaporated. The brownish oily
residue was dissolved in toluene (100 mL) and extracted with 10%
aqueous citric acid solution (50 mL). The aqueous solution was
basified (pH >12) with 20% aqueous NaOH solution and extracted
with toluene (50 mL × 4). The combined organic solutions were
washed with H2O (20 mL × 5) and brine (20 mL × 5), dried, and
evaporated to give a guanidine (3.54 g, 98%) as colorless solids, mp
97−100 °C: [α]D24.5 = −85.0° (c 1.04, CHCl3); IR (ATR) 1738, 1651
1H), 5.09 (d, J = 14.6 Hz, 1H), 7.18−7.20 (m, 4H), 7.31−7.36 (m,
6H), 7.44−7.52 (m, 3H), 7.70−7.72 (m, 2H); HRMS (ESI) calcd for
C30H36N3O2 470.280 75, found 470.279 63. Anal. Calcd for
C30H36BrN3O2: C, 65.45; H, 6.59; N, 7.63. Found: C, 65.22; H,
6.61; N, 7.60.
Preparation of (E)-4-[(tert-Butyldimethylsilyl)oxy]but-2-enal
(7). (Z)-4-[(tert-Butyldimethylsilyl)oxy]but-2-en-1-ol.18 To a suspen-
sion of NaH (1.10 g, 60% oil suspension, 27.6 mmol) in THF (40 mL)
was added 6 (2.28 mL, 27.7 mmol) under Ar, and the resulting
mixture was stirred at rt for 1 h. After addition of a solution of TBSCl
(4.16 g, 27.6 mmol) in THF (40 mL) at rt the mixture was stirred at rt
for 5 h and quenched with saturated NH4Cl aolution (20 mL). After
evaporation of the THF the residue was partitioned using H2O (50
mL) and Et2O (100 mL × 3). The combined organic solutions were
washed with brine (30 mL × 2), dried, and evaporated. The residue
was purified by column chromatopgrahy (hexane/AcOEt 10/1) to
afford the tert-butyldimethylsilyloxy alcohol (5.19 g, 93%) as a
1
cm−1; H NMR (400 MHz) δ 1.51 (s, 9H), 2.75 (br s, 6H), 3.90 (s,
2H), 4.26 and 4.34 (each d, J = 18.0 Hz), 7.13−7.16 (m, 4H), 7.27−
7.35 (m, 6H); HRMS (ESI) calcd for C23H30N3O2 380.233 80, found
380.232 41.
(4R,5R)-2-[(tert-Butoxycarbonyl)methyl]imino-1,3-dimethyl-4,5-
diphenylimidazolidinium Bromide (4).14a The guanidine (1.53 g, 4.0
mmol) and benzyl bromide (0.65 mL, 5.47 mmol) were dissolved in
dry MeCN (17.5 mL), and the resulting solution was stirred at rt for
12 h under Ar and evaporated. Washing the residual solid with 1/1
hexane/Et2O (15 mL) gave 4 (2.10 g, 95%) as colorless solids, mp
171−173 °C: [α]D25 = −95.0° (c 1.01, CHCl3); IR (ATR) 1742 cm−1;
1H NMR (400 MHz) δ 1.51 (s, 9H), 3.17 (s, 6H), 4.28 (d, J = 19.0
1
colorless oil: IR (ATR) 3359 cm−1; H NMR (400 MHz) δ 0.10 (s,
6H), 0.91 (s, 9H), 2.18 (s, 1H), 4.20 (dif d, J = 5.7 Hz, 2H), 4.27 (dif
d, J = 5.7 Hz, 2H), 5.65−5.73 (m, 2H).
(E)-4-[(tert-Butyldimethylsilyl)oxy]but-2-enal (7).18 A solution of
the alcohol (5.08 g, 25.1 mmol) in dry CH2Cl2 (30 mL) was added to
a stirred mixture of PCC (8.11 g, 37.7 mmol) and sodium acetate
Hz, 1H), 4.47 (d, J = 19.0 Hz, 1H), 4.68 (s, 2H), 4.73 (d, J = 14.6 Hz,
G
dx.doi.org/10.1021/jo301178b | J. Org. Chem. XXXX, XXX, XXX−XXX

The Journal of Organic Chemistry
Article
(3.12 g, 38.1 mmol) in dry CH2Cl2 (100 mL) under Ar. The resulting
mixture was stirred at rt for 3.5 h and evaporated. The residual black
solid was suspended in Et2O (500 mL) and filtered through Celite.
After evaporation of the filtrate the residue was purified by column
chromatography (hexane/AcOEt 10/1) to give 7 (4.11 g, 82%) as a
aqueous NaOH solution (1 mL) and H2O (4 mL) with ice cooling,
the mixture was extracted with AcOEt (20 mL × 3). The combined
organic solutions were washed with H2O (20 mL × 2) and brine (20
mL × 2), dried, and evaporated. Column chromatography of the
residue (hexane/AcOEt 2/3) afforded anti-10 (0.054 g, 84%) as a
colorless oil: IR (ATR) 3400 (br), 1725 cm−1; 1H NMR (400 MHz) δ
1.46 (s, 9H), 2.60 (br s, 3H), 3.39 (d, J = 4.8 Hz, 1H), 3.63 (d, J = 12.8
Hz, 1H), 3.88 (d, J = 12.8 Hz, 1H), 4.08 (d, J = 5.2 Hz, 2H), 4.37
(ddd, J = 6.0, 4.8, 1.2 Hz, 1H), 5.58 (ddt, J = 15.2, 6.0, 1.6 Hz, 1H),
5.88 (dtd, J = 15.2, 5.2, 1.6 Hz, 1H), 7.24−7.35 (m, 5H); 13C NMR
(100 MHz) δ 28.0, 52.6, 62.6, 65.2, 70.9, 82.1, 127.3, 128.41, 128.43,
128.6, 131.9, 139.2, 171.5; HRMS (ESI) calcd for C17H25NO4Na
330.168 13, found 330.168 55.
1
colorless oil: IR (ATR) 1693 cm−1; H NMR (400 MHz) δ 0.07 (s,
6H), 0.90 (s, 9H), 4.43 (dd, J = 3.0, 2.2 Hz, 2H), 6.38 (ddt, J = 15.4,
8.2, 2.2 Hz, 1H), 6.88 (dt, J = 15.4, 3.0 Hz, 1H), 9.58 (d, J = 8.2 Hz,
1H).
Asymmetric Aziridination. Freshly distilled TMG (0.69 mL, 5.50
mmol) was added to a solution of 4 (2.01 g, 3.64 mmol) in dry THF
(8 mL) at rt under Ar. To the above solution was slowly added a
solution of 7 (0.929 g, 4.64 mmol) in dry THF (4 mL), and the
resulting mixture was stirred at rt for 16.5 h and then dropped to a
solution of Ac2O (2 mL, 21.2 mmol) in MeCN (300 mL). The whole
was stirred at rt for 1 h and evaporated. The residue was purified by
flash chromatography (hexane/AcOEt 20/1) to give trans-8 (0.474 g,
31%, 77% ee) and cis-8 (0.445 g, 33%, 85% ee) as yellow oils,
respectively, between which trans-8 existed as a mixture of invertomers
in a ratio of 1.2:1.
Iodoamination of anti-9. To a stirred solution of anti-9 (0.153 g,
0.330 mmol) in AcOEt (4 mL) was successively added K2CO3 (0.156
g, 1.13 mmol) and iodine (0.250 g, 0.984 mmol) at −40 °C. The
mixture was stirred at the same temperature for 1 h, diluted with
AcOEt (20 mL), and extracted with 20% aqueous Na2S2O3 solution
(20 mL × 3). The organic solution was washed with H2O (20 mL × 3)
and brine (20 mL × 3), dried, and evaporated. Column
chromatography of the residue (hexane/AcOEt 5/1) afforded a 9/1
diastereoisomeric mixture of 11 and 12 as a yellow oil (0.161 g, 83%):
trans-(2S,3R)-tert-Butyl 1-Benzyl-3-[(E)-3-(tert-
butyldimethylsilyloxy)prop-1-enyl]aziridine-2-carboxylate
21
1
(trans-8): [α]D = +7.2° (c 1.09, CHCl3); IR (ATR) 1735 cm−1; H
NMR (400 MHz) for major invertomer δ 0.06 (s, 6H), 0.90 (s, 9H),
1.39 (s, 9H), 2.58 (d, J = 2.6 Hz, 1H), 2.77 (dd, J = 7.8, 2.6 Hz, 1H),
3.95 (d, J = 14.0 Hz, 1H), 4.13 (d, J = 14.0 Hz, 1H), 4.16 (d, J = 4.8
Hz, 2H), 5.47 (dd, J = 15.5, 7.8 Hz, 1H), 5.91 (dt, J = 15.5, 4.8 Hz,
1H), 7.21−7.36 (m, 5H); 1H NMR (400 MHz) for minor invertomer
δ 0.06 (s, 6H), 0.90 (s, 9H), 1.46 (s, 9H), 2.27 (d, J = 2.4 Hz, 1H),
3.06 (dd, J = 8.8, 2.4 Hz, 1H), 3.68 (d, J = 14.0 Hz, 1H), 3.87 (d, J =
14.0 Hz, 1H), 4.20 (d, J = 4.8 Hz, 2H), 5.70 (dd, J = 15.5, 8.2 Hz, 1H),
6.03 (dt, J = 15.5, 4.8 Hz, 1H), 7.21−7.34 (m, 5H); 13C NMR (100
MHz) for major invertomer δ −5.3, 18.3, 25.9, 43.0, 47.3, 54.4, 63.1,
81.5, 126.7, 127.9, 128.1, 128.2, 132.8, 139.2, 167.9; 13C NMR (100
MHz) for minor invertomer δ −5.3, 18.3, 27.9, 45.1, 47.7, 55.7, 62.9,
81.3, 122.0, 126.8, 127.5, 128.1, 137.1, 138.8, 169.4; HRMS (FAB)
calcd for C23H38NO3Si 404.2621, found 404.2600; HPLC (CHIR-
ALCEL OD-H, λ 254 nm, hexane/iPrOH 400/1, flow rate 0.5 mL/
min at 40 °C) tR for minor isomer 23.1 min, tR for major isomer 66.5
min.
1
IR (ATR) 1747 cm−1; H NMR (400 MHz) for major 11 δ 0.06 (s,
6H), 0.92 (s, 9H), 1.48 (s, 9H), 2.07 (s, 3H), 3.47 (d, J = 2.8 Hz, 1H),
3.69 (ddd, J = 7.8, 3.6, 2.8 Hz, 1H) 3.71 (dd, J = 11.7, 3.6 Hz, 1H),
3.78 (d, J = 14.4 Hz, 1H), 3.80 (dd, J = 11.7, 2.8 Hz, 1H), 4.13 (dd, J =
7.8, 5.2 Hz, 1H), 4.16 (d, J = 14.4 Hz, 1H), 5.46 (dd, J = 5.2, 2.8 Hz,
1H), 7.22−7.37 (m, 5H); 1H NMR (400 MHz) for minor 12 δ −0.01
(d, J = 4.8 Hz, 6H), 0.86 (s, 9H), 1.37 (s, 9H), 2.08 (s, 3H), 3.42−3.55
(m, 1H), 3.64 (d, J = 5.2 Hz, 1H), 3.73 (d, J = 13.7 Hz, 1H), 3.82 (d, J
= 13.7 Hz, 1H), 4.06 (d, J = 3.2 Hz, 2H), 4.52 (dd, J = 5.2, 5.2 Hz,
1H), 4.91 (dd, J = 5.2, 5.2 Hz, 1H), 7.22−7.37 (m, 5H); 13C NMR
(100 MHz) for major 11 δ −5.5, −5.4, 18.2, 20.7, 22.9, 25.8, 28.0,
51.2, 60.3, 69.2, 71.1, 81.9, 83.3, 127.0, 128.2, 128.3, 138.7, 169.9,
170.4; 13C NMR (100 MHz) for minor 12 δ −5.5, −5.4, 14.5, 21.0,
23.1, 26.6, 27.8, 59.4, 65.0, 69.9, 73.0, 74.8, 81.3, 127.2, 129.1, 138.5,
169.4, 169.6; HRMS (ESI) calcd for C25H40NO5NaSiI 612.161 81,
found 612.161 74.
Iodoamination of anti-10. To a stirred solution of anti-10 (0.061
g, 0.198 mmol) in THF (2 mL) was successively added K2CO3 (0.087
g, 0.631 mmol) and iodine (0.154 g, 0.606 mmol) at −35 °C. The
mixture was stirred at the same temperature for 2 h and evaporated.
After dilution with CH2Cl2 (20 mL), the solution was successively
washed with 20% aqueous Na2S2O3 solution (20 mL × 3), H2O (20
mL × 3), and brine (20 mL × 3), dried, and evaporated. Column
chromatography of the residue (hexane/AcOEt 5/1) afforded 13
(0.054 g, 62%) and 14 (0.011 g, 13%) as yellow oils, respectively.
(2S,3R,4R,5R)-tert-Butyl 1-Benzyl-3-hydroxy-5-hydroxymethyl-4-
c i s - ( 2 S , 3S ) - t e r t - B u t yl 1 - B e n z y l - 3 - [ (E ) - 3 - ( t e r t -
butyldimethylsilyloxy)prop-1-enyl]aziridine-2-carboxylate
21.5
1
(cis-8). [α]D = +2.7° (c 1.09, CHCl3); IR (ATR) 1717 cm−1; H
NMR (400 MHz) δ 0.05 (s, 6H), 0.89 (s, 9H), 1.45 (s, 9H), 2.32 (d, J
= 6.8 Hz, 1H), 2.41 (t-like, J = 7.2 Hz, 1H), 3.59 (d, J = 14.0 Hz, 1H),
3.71 (d, J = 14.0 Hz, 1H), 4.16 (d, J = 5.9 Hz, 2H), 5.71 (dd, J = 15.5,
8.0 Hz, 1H), 5.91 (dt, J = 15.5, 5.1 Hz, 1H), 7.22−7.35 (m, 5H); 13C
NMR (100 MHz) δ −5.2, 18.4, 25.9, 28.1, 45.0, 46.8, 63.1, 63.4, 81.3,
125.4, 126.9, 127.6, 128.2, 134.4, 137.9, 168.0; HRMS (FAB) calcd for
C23H37NO3NaSi 426.2440, found 426.2425; HPLC (CHIRALCEL
OD-H, λ 254 nm, hexane/iPrOH 400/1, flow rate 0.5 mL/min at 40
°C) tR for minor isomer 30.8 min, tR for major isomer 34.9 min.
(2S,3S,4E)-tert-Butyl 3-Acetoxy-2-benzylamino-6-(tert-
butyldimethylsilyloxy)hex-4-enoate (anti-9). A solution of
trans-8 (0.505 g, 1.25 mmol) in AcOH (1.6 mL, 28 mmol) was
stirred at rt for 1.5 h and evaporated. Column chromatography of the
residue (hexane/AcOEt 6/1) afforded anti-9 (0.529 mg, 91%) as a
1
iodopyrrolidine-2-carboxylate (13): IR (ATR) 3409, 1722 cm−1; H
NMR (400 MHz) δ 1.50 (s, 9H), 3.33 (bs, 1H), 3.60 (dd, J = 12.0, 0.8
Hz, 1H), 3.63 (s, 1H) 3.67 (dd, J = 12.0, 2.4 Hz, 1H), 3.83 (dt, J = 5.7,
2.4 Hz, 1H), 3.98 (d, J = 14.0 Hz, 1H), 4.03 (d, J = 14.0 Hz, 1H), 4.13
(dd, J = 5.7, 2.4 Hz, 1H), 4.57 (s, 1H), 7.27−7.32 (m, 5H); 13C NMR
(100 MHz) δ 26.3, 28.1, 51.6, 58.2, 71.9, 73.0, 82.1, 82.6, 127.4, 128.3,
128.6, 138.5, 170.8; HRMS (ESI) calcd for C17H24NO4NaI 456.064
77, found 456.064 88.
(2S,3R,4S,5S)-tert-Butyl 1-Benzyl-3-hydroxy-5-hydroxymethyl-4-
yellow oil: [α]D24 = +3.5° (c 0.96, CHCl3); IR (ATR) 1731 cm−1; H
1
1
iodopyrrolidine-2-carboxylate (14): IR (ATR) 3395, 1718 cm−1; H
NMR (400 MHz) δ 0.05 (s, 6H), 0.90 (s, 9H), 1.46 (s, 9H), 2.04 (s,
3H), 3.37 (d, J = 5.5 Hz, 1H), 3.70 (d, J = 13.2 Hz, 1H), 3.87 (d, J =
13.2 Hz, 1H), 4.17 (d, J = 4.0 Hz, 2H), 5.48 (dd, J = 6.7, 5.5 Hz, 1H),
5.74 (ddt, J = 15.5, 6.7, 1.6 Hz, 1H), 5.83 (dt, J = 15.5, 4.0 Hz, 1H),
7.21−7.35 (m, 5H); 13C NMR (100 MHz) δ −5.3, 18.3, 21.1, 25.9,
28.0, 52.1, 62.7, 64.0, 74.6, 81.7, 124.0, 127.0, 128.2, 128.3, 134.2,
139.6, 169.7, 171.0; HRMS (ESI) calcd for C25H41NO5NaSi 486.265
17, found 486.265 18.
(2S,3S,4E)-tert-Butyl 2-Benzylamino-3,6-dihydroxyhex-4-
enoate (anti-10). A solution of trans-8 (0.084 g, 0.209 mmol) in
THF (1 mL) was stirred with a solution of TsOH + H2O (0.049 g,
0.255 mmol) in H2O (1 mL) at rt for 15 h. After addition of 20%
NMR (400 MHz) δ 1.31 (s, 9H), 2.23 (d, J = 2.8 Hz, 1H), 3.48 (t, J =
5.5 Hz, 1H), 3.56 (d, J = 9.2 Hz, 1H), 3.66−3.68 (m, 3H), 3.84 (d, J =
13.2 Hz, 1H), 4.07 (d, J = 13.2 Hz, 1H), 4.08 (br, 1H), 4.49 (dd, J =
9.2, 3.6 Hz, 1H), 7.24−7.31 (m, 5H); 13C NMR (100 MHz) δ 27.8,
30.8, 58.1, 59.1, 71.0, 72.4, 76.6, 82.0, 127.5, 128.5, 128.9, 138.1, 172.1;
HRMS (FAB) calcd for C17H24NO4NaI 456.0648, found 456.0656.
(1R,2S,4R,5S)-tert-Butyl 3-Benzyl-4-(hydroxymethyl)-6-oxa-
3-azabicyclo[3.1.0]hexane-2-carboxylate (15). A mixture of 13
(0.179 g, 0.414 mmol) and K2CO3 (0.148 g, 1.07 mmol) in MeOH (3
mL) was stirred at rt for 0.5 h, quenched with saturated aqueous
NH4Cl solution (3 mL), and extracted with AcOEt (20 mL × 4). The
combined organic solutions were washed with H2O (20 mL × 3) and
H
dx.doi.org/10.1021/jo301178b | J. Org. Chem. XXXX, XXX, XXX−XXX

The Journal of Organic Chemistry
Article
brine (20 mL × 2), dried, and evaporated. Column chromatography of
the residue (hexane/AcOEt 2/1) gave 15 (0.117 g, 93%) as a yellow
oil: IR (ATR) 3450, 1726 cm−1; 1H NMR (400 MHz) δ 1.47 (s, 9H),
2.44 (br s, 1H), 3.41 (s, 1H), 3.58 (d, J = 2.8 Hz, 1H), 3.74 (s, 1H),
3.77 (d, J = 14.0 Hz, 1H), 3.95 (d, J = 14.0 Hz, 1H), 3.80 (d, J = 2.8
Hz, 1H), 3.90 (dd, J = 11.2, 4.0 Hz, 1H), 3.94 (d, J = 11.2 Hz, 1H),
7.25−7.30 (m, 5H); 13C NMR (100 MHz) δ 28.2, 50.8, 55.0, 57.5,
59.8, 61.7, 64.0, 82.1, 127.4, 128.4, 128.6, 139.5, 170.0; HRMS (ESI)
calcd for C17H23NO4Na 328.152 48, found 328.155 47.
(+)-DMDP [(2R,3R,4R,5R)-3,4-Dihydroxy-2,5-bis-
(hydroxymethyl)pyrrolidine] (1). A mixture of 19 (0.064 g, 0.251
mmol) and 20% Pd(OH)2 on C (0.021 g) in a solution of HCl in
MeOH (1.3 mL), which was prepared by passing HCl gas (NaCl (50
g) and concentrated H2SO4 (10 mL)) into MeOH (100 mL), was
stirred at rt and at atmospheric pressure for 1 h under hydrogen. The
catalyst was filtered off through Celite, and the filtrate was evaporated.
Column chromatography of the residue (DOWEX 50WX8 100−200
H FORM, EtOH → H2O → 2 M aqueous NH3 solution) afforded 1
(0.035 g, 71%) as brownish solids: mp 112−114 °C (lit.8 mp 112−115
́
Prevost-Type Displacement of a 9/1 Mixture of 11 and 12. A
°C); [α]D = +58.8° (c 0.10, H2O) (lit.8 [α]D = +55.4° (c 1.25,
24
28
solution of a 9/1 mixture of 11 and 12 (0.161 g, 0.273 mmol) in
AcOH (1 mL) was added to AcOAg (0.122 g, 0.733 mmol) under Ar,
and the resulting mixture was stirred at 40 °C for 15 h and filtered
through Celite. After evaporation of the filtrate column chromatog-
raphy of the residue (hexane/AcOEt 10/1) afforded 16 (0.073 g, 57%)
and 17 (0.026 g, 26%) as colorless oils, respectively.
1
H2O)); IR (ATR) 3293 cm−1; H NMR (400 MHz, D2O) δ 3.00−
3.06 (m, 2H), 3.61 (dd, J = 11.5, 6.4 Hz, 2H), 3.68 (ddd, J = 11.5, 4.1
Hz, 2H), 3.81 (d, J = 7.8 Hz, 1H), 3.84 (dd, J = 10.1, 6.9 Hz, 1H); 13C
NMR (100 MHz, D2O) δ 61.8, 62.3, 78.1; HRMS (FAB) calcd for
C6H14NO4 164.0923, found 164.0921.
(2S,3R,4E)-tert-Butyl 3-Acetoxy-2-benzylamino-6-(tert-
butyldimethylsilyloxy)hex-4-enoate (syn-9). A solution of cis-8
(0.023 g, 0.057 mmol) in AcOH (0.07 mL, 1.26 mmol) was stirred at
rt for 5.5 h and evaporated. Column chromatography of the residue
(hexane/AcOEt 10/1) afforded syn-9 (0.025 g, 93%) as a yellow oil:
(2S,3R,4R,5S)-tert-Butyl 1-Benzyl-3,4-diacetoxy-5-[(tert-
23.4
butyldimethylsilyloxy)methyl]prolinate (16): [α]D
= −20.8° (c
1
2.00, CHCl3); IR (ATR) 1744 cm−1; H NMR (400 MHz) δ 0.07 (s,
3H), 0.08 (s, 3H), 0.92 (s, 9H), 1.48 (s, 9H), 2.06 (s, 3H), 2.07 (s,
3H), 3.31 (dd, J = 4.0, 4.0 Hz, 1H), 3.63 (d, J = 3.2 Hz, 1H), 3.75 (dd,
J = 10.8, 4.0 Hz, 1H), 3.81 (dd, J = 10.8, 4.0 Hz, 1H), 3.85 (d, J = 14.4
Hz, 1H), 4.09 (d, J = 14.4 Hz, 1H), 5.18 (dd, J = 4.0, 3.2 Hz, 1H), 5.27
(dd, J = 3.2, 3.2 Hz, 1H), 7.24 (dd, J = 7.2, 7.2 Hz, 1H), 7.31 (dd, J =
7.2, 7.2 Hz, 2H), 7.37 (d, J = 7.2 Hz, 2H); 13C NMR (100 MHz) δ
−5.6, −5.5, 18.1, 20.8, 20.9, 25.8, 28.0, 51.5, 62.3, 66.4, 69.1, 79.0, 79.3,
81.5, 127.0, 128.25, 128.27, 138.8, 170.0, 170.3, 170.4; HRMS (ESI)
calcd for C27H43NO7NaSi 544.270 65, found 544.274 06.
1
IR (ATR) 1733 cm−1; H NMR (400 MHz) δ 0.07 (s, 6H), 0.92 (s,
9H), 1.45 (s, 9H), 2.03 (s, 3H), 3.30 (d, J = 4.4 Hz, 1H), 3.64 (d, J =
13.2 Hz, 1H), 3.89 (d, J = 13.2 Hz, 1H), 4.18 (d, J = 1.6 Hz, 2H), 5.57
(dd, J = 5.2, 4.4 Hz, 1H), 5.84−5.88 (m, 2H), 7.21−7.35 (m, 5H); 13C
NMR (100 MHz) δ −5.31, −5.28, 18.4, 21.0, 25.9, 28.0, 52.2, 62.7,
63.9, 74.6, 81.7, 124.5, 127.0, 128.27, 128.29, 134.7, 139.8, 169.8,
171.3; HRMS (ESI) calcd for C25H41NO5NaSi 486.265 17, found
486.261 15.
tert-Butyl 1-Benzyl-5-[(tert-butyldimethylsilyloxy)methyl]-1H-pyr-
role-2-carboxylate (17): IR (ATR) 1698 cm−1; 1H NMR (400 MHz)
δ −0.01 (s, 6H), 0.85 (s, 9H), 1.45 (s, 9H), 4.51 (s, 2H), 5.70 (s, 2H),
6.10 (d, J = 4.0 Hz, 1H), 6.91 (d, J = 4.0 Hz, 1H), 6.92 (d, J = 7.2 Hz,
2H), 7.18 (dd, J = 7.6, 7.6 Hz, 1H), 7.25 (dd, J = 7.6, 7.6 Hz, 2H); 13C
NMR (100 MHz) δ −5.4, 18.2, 25.8, 28.3, 48.3, 57.6, 80.3, 108.5,
117.0, 124.9, 125.7, 126.7, 128.4, 138.6, 138.9, 160.6; HRMS (ESI)
calcd for C23H35NO3NaSi 424.228 39, found 424.226 39.
(2S,3R,4E)-tert-Butyl 2-Benzylamino-3,6-dihydroxyhex-4-
enoate (syn-10). A solution of cis-8 (0.538 g, 1.33 mmol) in dry
THF (5 mL) was stirred with a solution of TsOH + H2O (0.441 g,
2.32 mmol) in H2O (6 mL) at rt for 4.5 h. After addition of 20%
aqueous NaOH solution (6 mL) and H2O (16 mL) with ice cooling,
the mixture was extracted with AcOEt (50 mL × 3). The combined
organic solutions were washed with H2O (100 mL × 2) and brine
(100 mL × 2), dried, and evaporated. Column chromatography of the
residue (hexane/AcOEt 1/2) afforded syn-10 (0.341 g, 83%) as
colorless needles: mp 73−75 °C; [α]D19 = −21.4° (c 1.03, CHCl3); IR
(2R,3R,4R,5S)-1-Benzyl-2-[(tert-butyldimethylsilyloxy)-
methyl]-3,4-dihydroxy-5-(hydroxymethyl)pyrrolidine (18). A
mixture of 16 (0.101 g, 0.194 mmol) and LiBH4 (0.091 g, 4.17
mmol) in dry THF (1.5 mL) was refluxed for 10 h under Ar. To the
mixture were successively added THF (5 mL), MeOH (4 mL), and
saturated aqueous NH4Cl solution (1 mL), and then the whole
mixture was stirred at rt for 10 min. After addition of H2O (20 mL),
the mixture was extracted with AcOEt (30 mL × 3). The combined
organic solutions were washed with H2O (30 mL × 2) and brine (30
mL × 2), dried, and evaporated. Column chromatography of the
residue (hexane/AcOEt 1/2) afforded 18 (0.062 g, 87%) as a colorless
oil: [α]D23 = −21.2° (c 2.01, CHCl3); IR (ATR) 3342 cm−1; 1H NMR
(400 MHz) δ 0.14 (s, 3H), 0.16 (s, 3H), 0.95 (s, 9H), 1.75−2.30 (br,
2H), 3.15 (s, 1H), 3.20 (s, 1H), 3.62 (dd, J = 10.8, 1.5 Hz, 1H), 3.64
(dd, J = 11.2, 1.3 Hz, 1H), 3.70 (dd, J = 11.2, 3.1 Hz, 1H), 3.86 (dd, J
= 10.8, 2.9 Hz, 1H), 3.94 (s, 1H), 3.95 (s, 2H) 4.01 (s, 1H), 4.35−4.55
(br, 1H), 7.22−7.36 (m, 5H); 13C NMR (100 MHz) δ −5.7, −5.4,
18.2, 25.9, 51.2, 60.9, 62.4, 70.0, 71.8, 80.3, 80.4, 127.0, 127.7, 128.5,
139.5; HRMS (ESI) calcd for C19H34NO4Si 368.225 71, found
368.228 48.
1
(ATR) 3400, 1721 cm−1; H NMR (400 MHz) δ 1.44 (s, 9H), 3.06
(d, J = 7.5 Hz, 1H), 3.71 (d, J = 13.2 Hz, 1H), 3.84 (d, J = 13.2 Hz,
1H), 4.03 (t-like, J = 7.0 Hz, 1H), 4.13 (br d, J = 5.0 Hz, 2H), 5.70
(ddt, J = 15.2, 6.8, 1.6 Hz, 1H), 5.91 (dt, J = 15.2, 5.0 Hz, 1H), 7.25−
7.36 (m, 5 H); 13C NMR (100 MHz) δ 28.1, 52.6, 62.8, 66.5, 72.5,
82.1, 127.4, 128.3, 128.5, 129.7, 132.6, 139.1, 172.1; HRMS (ESI)
calcd for C17H26NO4 308.1862, found 308.1876; HPLC (CHIR-
ALCEL OD-H, λ 254 nm, hexane/iPrOH 20/1, flow rate, 0.5 mL/min
at 40 °C) tR for minor isomer 33.6 min, tR for major isomer 35.8 min.
Iodoamination of syn-9. To a stirred solution of syn-9 (0.020 g,
0.043 mmol) in CH2Cl2 (0.5 mL) was successively added K2CO3
(0.018 g, 0.13 mmol) and iodine (0.033 g, 0.13 mmol) at −20 °C. The
mixture was stirred at the same temperature for 1 h, diluted with
CH2Cl2 (20 mL), and extracted with 20% aqueous Na2S2O3 solution
(10 mL × 3). The organic solution was washed with H2O (10 mL × 3)
and brine (10 mL × 3), dried, and evaporated to give a 11/1
diastereoisomeric mixture of 22 and 23 (0.027 g, quantitative) as a
yellow oil, which was used for the next step without any purification:
IR (ATR) 1751, 1733 cm−1; 1H NMR (400 MHz) for major 22 δ 0.07
(s, 6H), 0.92 (s, 9H), 1.46 (s, 9H), 2.13 (s, 3H), 3.59 (dd, J = 11.5, 2.8
Hz, 1H), 3.73 (dd, J = 11.5, 2.8 Hz, 1H), 3.79 (dt, J = 6.8, 2.8 Hz, 1H),
3.89 (d, J = 6.8 Hz, 1H), 3.89 (d, J = 14.0 Hz, 1H), 4.07 (d, J = 14.0
Hz, 1H), 4.53 (dd, J = 6.8, 6.8 Hz, 1H), 5.32 (dd, J = 6.8, 6.8 Hz, 1H),
(2R,3R,4R,5R)-1-Benzyl-2,5-bis(hydroxymethyl)-3,4-dihy-
droxypyrrolidine (19). To a stirred solution of 18 (0.101 g, 0.272
mmol) in dry THF (0.5 mL) was added a 1.0 M solution of TBAF in
THF (0.54 mL, 0.54 mmol) at rt under Ar. The whole mixture was
stirred at rt for 0.5 h and evaporated. Column chromatography of the
residue (AcOEt/MeOH 5/1) afforded 19 (0.064 g, 92%) as colorless
19
1
needles: mp 132−133 °C; [α]D = −20.8° (c 0.31, MeOH); IR
7.23−7.38 (m, 5H); H NMR (400 MHz) for minor 23 δ −0.01 (s,
1
(ATR) 3294 cm−1; H NMR (400 MHz, CD3OD) δ 3.03 (m, 2H),
6H), 0.82 (s, 9H), 1.37 (s, 9H), 2.04 (s, 3H), 3.34 (dt, J = 10.0, 5.2 Hz,
1H), 3.47−3.56 (m, 2H), 3.89 (d, J = 14.9 Hz, 1H), 4.07 (d, J = 14.9
Hz, 1H), 4.08 (d, J = 2.4 Hz, 1H), 4.19 (dd, J = 4.0, 4.0 Hz, 1H), 5.50
(dd, J = 6.0, 3.6 Hz, 1H), 7.23−7.38 (m, 5H); 13C NMR (100 MHz)
for major 22 δ −5.6, −5.4, 18.2, 21.3, 25.9, 26.7, 28.1, 52.0, 60.7, 66.6,
70.5, 71.2, 81.4, 127.0, 128.27, 128.30, 138.9, 168.9, 169.5; HRMS
(ESI) calcd for C25H40NO5NaSiI 612.161 81, found 612.158 90.
3.60 (dd, J = 11.2, 2.8 Hz, 2H), 3.71 (dd, J = 11.4, 4.8 Hz, 2H), 3.96
(dd, J = 2.4, 1.3 Hz, 2H), 3.96 (d, J = 14.3 Hz, 1H), 4.03 (d, J = 14.3
Hz, 1H), 7.19 (dd, J = 7.5, 7.5 Hz, 1H), 7.28 (dd, J = 7.5, 7.5 Hz, 2H),
7.41 (d, J = 7.5 Hz, 2H); 13C NMR (100 MHz, CD3OD) δ 52.6, 61.6,
71.0, 80.7, 127.8, 129.2, 129.3, 141.2; HRMS (ESI) calcd for
C13H19NO4Na 276.121 18, found 276.120 01.
I
dx.doi.org/10.1021/jo301178b | J. Org. Chem. XXXX, XXX, XXX−XXX

The Journal of Organic Chemistry
Article
Iodoamination of syn-10. To a stirred solution of syn-10 (0.116
g, 0.377 mmol) in CH2Cl2 (5 mL) was successively added K2CO3
(0.154 g, 1.11 mmol) and iodine (0.287 g, 1.13 mmol) at −20 °C. The
mixture was stirred at the same temperature for 3 h and evaporated.
After dilution with CH2Cl2 (40 mL), the mixture was successively
washed with 20% aqueous Na2S2O3 solution (20 mL × 3), H2O (20
mL × 3), and brine (20 mL × 3), dried, and evaporated. Column
chromatography of the residue (hexane/AcOEt 2/1) afforded 25
(0.147 g, 91%) and 26 (0.006 g, 3%) as yellow oils, respectively.
(2S,3S,4R,5R)-tert-Butyl 1-Benzyl-3-hydroxy-5-hydroxymethyl-4-
3.03 (d, J = 6.9 Hz, 1H, exchangeable), 3.39 (br s, 1H), 3.58 (dd, J =
11.4, 3.2 Hz, 1H), 3.66 (dd, J = 11.4, 1.4 Hz, 1H), 3.72 (d, J = 13.3 Hz,
1H), 3.84 (d, J = 13.3 Hz, 1H), 3.80 (d, J = 6.8 Hz, 1H), 4.09 (dd, J =
6.4, 2.0 Hz, 1H), 4.14 (t-like, J = 6.8 Hz, 1H), 7.23−7.33 (m, 5H); 13C
NMR (100 MHz) δ 28.1, 53.3, 60.6, 68.3, 71.2, 72.7, 74.9, 83.2, 127.6,
128.5, 128.6, 138.0, 174.4; HRMS (ESI) calcd for C17H25NO5Na
346.163 04, found 346.165 87.
(2S,3S,4R,5S)-tert-Butyl 1-Benzyl-3,4-dihydroxy-5-[(tert-
butyldimethylsilyloxy)methyl]prolinate (31). A mixture of 30
(0.057 g, 0.18 mmol), TBSCl (0.035 g, 0.23 mmol), and imidazole
(0.026 g, 0.38 mmol) in DMF (3 mL) was stirred at rt for 1 h and
extracted with AcOEt (20 mL × 3) after addition of saturated aqueous
NH4Cl solution (6 mL). The combined organic solutions were washed
with H2O (20 mL × 2) and brine (20 mL × 2), dried, and evaporated.
1
iodopyrrolidine-2-carboxylate (25): IR (ATR) 3400, 1725 cm−1; H
NMR (400 MHz) δ 1.51 (s, 9H), 2.70 (d, J = 7.2 Hz, 1H), 3.63 (d, J =
12.0 Hz, 1H), 3.73 (dd, J = 12.0, 2.5 Hz, 1H), 3.89 (d, J = 7.0 Hz, 1H),
3.90 (s, 1H), 3.94 (s, 2H), 4.01 (dd, J = 13.4, 7.0 Hz, 1H), 4.63 (t-like,
J = 7.0 Hz, 1H), 7.27−7.35 (m, 5H); 13C NMR (100 MHz) δ 28.2,
33.3, 52.1, 58.4, 67.6, 69.6, 71.5, 82.5, 127.5, 128.4, 128.6, 138.3, 169.8;
HRMS (ESI) calcd for C17H24NO4NaI: 456.064 77, found 456.065 67.
(2S,3S,4S,5S)-tert-Butyl 1-Benzyl-3-hydroxy-5-hydroxymethyl-4-
Column chromatography of the residue (hexane/AcOEt 6/1) afforded
16
31 (0.057 g, 74%) as colorless needles: mp 79−81 °C; [α]D
=
−33.5° (c 1.15, CHCl3); IR (ATR) 3410, 1700 cm−1; H NMR (400
MHz) δ −0.06 (s, 3H), −0.05 (s, 3H), 0.91 (s, 9H), 1.43 (s, 9H), 3.00
(d, J = 8.7 Hz, 1H, exchangeable), 3.31 (t-like, J = 3.5 Hz, 1H), 3.56
(dd, J = 11.0, 4.4 Hz, 1H), 3.59 (dd, J = 11.0, 3.6 Hz, 1H), 3.72 (d, J =
7.6 Hz, 1H), 3.79 (d, J = 13.7 Hz, 1H), 3.92 (d, J = 13.7 Hz, 1H), 3.99
(dd, J = 5.7, 1.0 Hz, 1H), 4.36 (dd, J = 7.6, 5.7 Hz, 1H), 7.24−7.30 (m,
5H); 13C NMR (100 MHz) δ −5.5, 18.2, 25.9, 28.0, 53.7, 62.9, 68.5,
71.0, 71.4, 75.0, 82.5, 127.1, 128.2, 128.5, 138.8, 174.6; HRMS (ESI)
calcd for C23H39NO5NaSi 460.249 52, found 460.248 82.
1
1
iodopyrrolidine-2-carboxylate (26): IR (ATR) 3357, 1723 cm−1; H
NMR (400 MHz) δ 1.41 (s, 9H), 3.17 (dd, J = 11.4, 3.7 Hz, 1H), 3.46
(d, J = 11.4 Hz, 1H), 3.70 (t-like, J = 3.7 Hz, 1H), 3.95 (d, J = 12.8 Hz,
1H), 3.99 (d, J = 12.8 Hz, 1H), 4.12 (d, J = 6.4 Hz, 1H), 4.13 (dd, J =
6.4, 4.1 Hz, 1H), 4.56 (dd, J = 6.4, 3.7 Hz, 1H), 7.26−7.36 (m, 5H);
13C NMR (100 MHz) δ 28.0, 28.3, 59.2, 62.2, 69.3, 74.1, 80.5, 82.5,
127.9, 128.5, 129.2, 137.4, 170.8; HRMS (ESI) calcd for
C17H24NO4NaI 456.064 77, found 456.062 04.
( 3 a S , 4 S , 6 S , 6 a R ) - t e r t - B u t y l 5 - B e n z y l - 6 - [ ( t e r t -
butyldimethylsilyloxy)methyl]-2,2-dimethyltetrahydro[1,3]-
dioxolo[4,5-c]pyrrole-4-carboxylate (32). A mixture of 31 (0.0103
g, 0.0235 mmol) and TsOH + H2O (0.0065 g, 0.0342 mmol) in 2,2-
dimethoxypropane (0.3 mL) was stirred at rt for 1 h and evaporated
after addition of triethylamine (0.1 mL). Column chromatography of
the residue (hexane/AcOEt 4/1) afforded 32 (0.0086 g, 77%) as a
colorless oil: [α]D21 = −67.7° (c 0.66, CHCl3); IR (ATR) 1740 cm−1;
1H NMR (400 MHz) δ 0.05 (s, 3H), 0.09 (s, 3H), 0.92 (s, 9H), 1.33
(s, 3H), 1.56 (s, 3H), 1.49 (s, 9H), 3.19 (s, 1H), 3.42 (dd, J = 11.0, 2.6
Hz, 1H), 3.61 (d, J = 13.5 Hz, 1H), 3.87 (dd, J = 11.0, 2.2 Hz, 1H),
3.95 (d, J = 6.6 Hz, 1H), 4.07 (d, J = 13.5 Hz, 1H), 4.59 (d, J = 6.2 Hz,
1H), 4.91 (dd, J = 6.4, 6.2 Hz, 1H), 7.22 (dd, J = 7.3, 7.3 Hz, 1H), 7.30
(dd, J = 7.3, 7.3 Hz, 2H), 7.46 (d, J = 7.7 Hz, 2H); 13C NMR (100
MHz) δ −5.7, −5.5, 18.0, 25.8, 25.9, 26.6, 28.2, 51.8, 61.6, 64.6, 70.9,
80.6, 81.3, 83.0, 112.0, 126.8, 128.2, 128.3, 139.1, 169.5; HRMS (ESI)
calcd for C26H43NO5NaSi 500.280 82, found 500.277 02.
(2S,3S,4R,5R)-tert-Butyl 5-Acetoxymethyl-1-benzyl-3-hy-
droxy-4-iodoprolinate (28). A solution of 25 (0.383 g, 0.884
mmol) in Ac2O (2 mL, 21.2 mmol) was stirred at rt for 5 h and
evaporated. Column chromatography of the residue (hexane/AcOEt
14.5
3/1) afforded 28 (0.399 g, 95%) as a yellow oil: [α]D = +2.4° (c
1
3.22, CHCl3); IR (ATR) 3440, 1739 cm−1; H NMR (400 MHz) δ
1.48 (s, 9H), 2.08 (s, 3H), 2.85 (br, 1H), 3.82 (d, J = 6.2 Hz, 1H), 3.83
(d, J = 14.0 Hz, 1H), 4.05 (d, J = 14.0 Hz, 1H), 3.91 (dt, J = 6.8, 3.2
Hz, 1H), 4.03−4.12 (m, 1H) 4.07 (dd, J = 12.5, 3.2 Hz, 1H), 4.31 (dd,
J = 12.5, 3.2 Hz, 1H), 4.43 (dd, J = 6.8, 6.8 Hz, 1H), 7.21−7.30 (m,
5H); 13C NMR (100 MHz) δ 20.9, 28.1, 32.9, 51.7, 61.8, 66.9, 67.5,
70.1, 82.3, 127.2, 128.25, 128.31, 138.1, 169.7, 170.5; HRMS (ESI)
calcd for C19H26NO5NaI 498.075 33, found 498.077 13.
́
Prevost-Type Displacement of 28. A mixture of 28 (0.120 g,
0.253 mmol) and AcOAg (0.114 g, 0.684 mmol) in AcOH (3 mL) and
CH2Cl2 (1 mL) was stirred at rt for 19 h under Ar and filtered through
Celite. After evaporation of the filtrate column chromatography of the
residue (hexane/AcOEt 2/1) afforded 29 (0.061 g, 59%) as a colorless
oil, which was estimated to be a ca. 2/1 mixture: IR (ATR) 3500, 1740
cm−1; 1H NMR (400 MHz) for a major isomer δ 1.46 (s, 9H), 2.07 (s,
3H), 2.09 (s, 3H), 3.48−3.55 (m, 1H), 3.75 (d, J = 7.6 Hz, 1H), 3.75
(d, J = 13.6 Hz, 1H), 3.83 (d, J = 12.4 Hz, 1H, exchangeable), 4.00 (d,
J = 13.6 Hz, 1H), 4.07 (dd, J = 11.6, 3.6 Hz, 1H), 4.25 (dd, J = 12.0,
6.0 Hz, 1H), 4.38 (dd, J = 11.6, 5.2 Hz, 1H), 5.05 (t-like, J = 6.8 Hz,
(3aS,4S,6S,6aR)-Di-tert-butyl 6-[(tert-Butyldimethylsilyloxy)-
methyl]-2,2-dimethyltetrahydro[1,3]dioxolo[4,5-c]pyrrole-4,5-
dicarboxylate (33). A mixture of 32 (0.0395 g, 0.0827 mmol),
(Boc)2O (0.0345 g, 0.158 mmol), and 20% Pd(OH)2 on C (0.0123 g)
in AcOEt (2 mL) was stirred at rt for 44 h and then at 40 °C for 1 h
and filtered through Celite. After evaporation of the filtrate, column
chromatography of the residue (hexane/AcOEt 10/1) afforded 33
(0.0344 g, 85%) as a colorless oil, which exists as rotational isomers in
1
21.5
1H), 7.21−7.31 (m, 5H); H NMR (400 MHz) for a minor isomer δ
a ratio of 7/3: [α]D = −89.2° (c 0.688, CHCl3); IR (ATR) 1756,
1700 cm−1; 1H NMR (400 MHz) for a major rotamer δ 0.01 (s, 3H),
0.02 (s, 3H), 0.88 (s, 9H), 1.30 (s, 3H), 1.44 (s, 3H), 1.42 (s, 9H),
1.49 (s, 9H), 3.56 (dd, J = 10.1, 1.8 Hz, 1H), 4.14 (dd, J = 10.1, 1.8
Hz, 1H), 4.26 (s, 1H), 4.28 (d, J = 7.8 Hz, 1H), 4.65 (d, J = 6.0 Hz,
1.51 (s, 9H), 2.08 (s, 3H) 2.10 (s, 3H), 3.48−3.55 (m, 1H), 3.63 (d, J
= 7.2 Hz, 1H), 3.96 (d, J = 13.6 Hz, 1H), 4.01 (d, J = 13.6 Hz, 1H),
4.07 (dd, J = 12.0, 4.0 Hz, 1H), 4.38 (dd, J = 12.0, 4.0 Hz, 1H), 4.41
(t-like, J = 6.4 Hz, 1H), 5.11 (dd, J = 6.4, 2.8 Hz, 1H), 7.21−7.31 (m,
5H); 13C NMR (100 MHz) for a major isomer δ 20.8, 28.0, 53.3, 63.6,
65.0, 69.9, 72.1, 72.9, 82.8, 127.4, 128.3, 137.8, 169.5, 170.8, 173.2; 13C
NMR (100 MHz) for a minor isomer δ 20.5, 28.2, 51.7, 62.4, 65.0,
65.1, 70.4, 75.0, 81.9, 127.2, 128.3, 128.4, 138.4, 170.4, 170.7, 170.8;
HRMS (FAB) calcd for C21H30NO7 408.2022, found 408.2019.
(2S,3S,4R,5R)-tert-Butyl 1-Benzyl-3,4-dihydroxy-5-
(hydroxymethyl)prolinate (30). A mixture of 29 (0.125 g, 0.307
mmol) and K2CO3 (0.129 g, 0.932 mmol) in MeOH (10 mL) was
stirred at rt for 1 h and extracted with CHCl3 (30 mL × 3) after
addition of H2O (10 mL). The combined organic solutions were
washed with H2O (20 mL × 2) and brine (20 mL × 2), dried, and
1
1H), 4.88 (t-like, J = 7.2 Hz, 1H); H NMR (400 MHz) for a minor
rotamer δ 0.02 (s, 3H), 0.04 (s, 3H), 0.88 (s, 9H), 1.30 (s, 3H), 1.48
(s, 3H), 1.45 (s, 9H), 1.48 (s, 9H), 3.63 (dd, J = 10.1, 1.8 Hz, 1H),
3.87 (dd, J = 10.1, 2.7 Hz, 1H), 4.13 (s, 1H), 4.37 (d, J = 7.8 Hz, 1H),
4.67 (d, J = 6.0 Hz, 1H), 4.86 (t-like, J = 7.2 Hz, 1H); 13C NMR (100
MHz) for a major rotamer δ −5.7, −5.3, 18.1, 24.6, 25.5, 25.9, 28.27,
28.32, 62.0, 64.0, 65.8, 79.9, 80.2, 80.9, 82.2, 112.2, 153.6, 167.8; 13C
NMR (100 MHz) for a minor rotamer δ −5.7, −5.5, 18.1, 24.6, 25.5,
25.9, 28.1, 28.4, 63.5, 63.9, 77.2, 78.6, 80.0, 80.9, 83.3, 112.2, 153.6,
167.2; HRMS (ESI) calcd for C24H45NO7NaSi 510.286 30, found
510.284 04.
evaporated. Column chromatography of the residue (AcOEt) afforded
(3aR,4S,6R,6aR)-tert-Butyl 4-[(tert-Butyldimethylsilyloxy)-
methyl]-6-hydroxymethyl-2,2-dimethyltetrahydro[1,3]-
dioxolo[4,5-c]pyrrole-5-carboxylate (34). A mixture of 33 (0.0116
g, 0.0238 mmol) and LiBH4 (0.0026 g, 0.1194 mmol)) in MeOH (1.2
17
30 (0.093 g, 94%) as colorless needles: mp 106−108 °C; [α]D
=
−57.1° (c 1.86, CHCl3); IR (ATR) 3440 (br), 1700 cm−1; H NMR
(400 MHz) δ 1.50 (s, 9H), 2.20 (d, J = 9.6 Hz, 1H, exchangeable),
1
J
dx.doi.org/10.1021/jo301178b | J. Org. Chem. XXXX, XXX, XXX−XXX

The Journal of Organic Chemistry
Article
mL) was stirred with heating at 70 °C for 7 h under Ar, quenched with
saturated aqueous NH4Cl solution (0.6 mL), and extracted with
AcOEt (20 mL × 2). The combined organic solutions were washed
with H2O (1 mL × 2) and brine (1 mL × 2), dried, and evaporated to
give 34 (0.0078 g, 76%) as a yellow oil, which exists as rotational
isomers in a ratio of 6/1: IR (ATR) 3430, 1680 cm−1; 1H NMR (600
MHz) for a major rotamer δ 0.047 (s, 3H), 0.052 (s, 3H), 0.89 (s,
9H), 1.32 (s, 3H), 1.45 (s, 3H), 1.47 (s, 9H), 3.67 (dd, J = 10.4, 2.2
Hz, 1H), 3.76 (ddd, J = 13.2, 7.4, 2.5 Hz, 1H) 3.84 (dd, J = 10.4, 3.6
Hz, 1H), 3.87−3.92 (m, 2H), 3.98 (t-like, J = 2.8 Hz, 1H), 4.61 (d, J =
6.0 Hz, 1H), 4.75 (t-like, J = 6.0 Hz, 1H), 5.27 (dd, J = 11.0, 2.7 Hz,
1H, exchangeable); 1H NMR (600 MHz) for a minor rotamer δ 0.025
(s, 3H), 0.033 (s, 3H), 0.88 (s, 9H), 1.26 (s, 3H), 1.37 (s, 3H), 1.47 (s,
9H), 2.88 (dd, J = 11.0, 6.6 Hz, 1H, exchangeable), 3.57 (d, J = 10.4
Hz, 1H), 3.66−3.68 (m, 1H), 3.92−3.96 (m, 2H), 4.09 (dd, J = 11.0,
6.0 Hz, 1H), 4.17 (dd, J = 11.0, 2.5 Hz, 1H), 4.65 (d, J = 6.0 Hz, 1H),
4.85 (t-like, J = 6.6 Hz, 1H); 13C NMR (100 MHz) for a major
rotamer δ −5.6, −5.5, 18.1, 24.7, 25.9, 26.0, 28.4, 63.1, 63.4, 65.0, 66.1,
80.4, 80.8, 81.1, 110.9, 155.9; HRMS (ESI) calcd for C20H39NO6NaSi
440.244 43, found 440.240 66.
(3aR,4S,6S,6aS)-tert-Butyl 4-[(tert-Butyldimethylsilyloxy)-
methyl]-6-formyl-2,2-dimethyltetrahydro[1,3]dioxolo[4,5-c]-
pyrrole-5-carboxylate (5). A mixture of 34 (0.0078 g, 0.0187
mmol), DMP (0.0119 g, 0.0281 mmol), and NaHCO3 (0.0047 g,
0.0559 mmol) in dry CH2Cl2 (0.4 mL) was stirred at rt for 1 h,
quenched with saturated aqueous NaHCO3 solution (0.2 mL), and
extracted with AcOEt (20 mL × 2). The combined organic solutions
were washed with H2O (1 mL × 2) and brine (1 mL × 2), dried, and
evaporated. Purification of the residue by column chromatography
(hexane/AcOEt 10/1) afforded 5 (0.0052 g, 67%) as colorless prisms,
which exists as rotational isomers in a ratio of 2/1: mp 65−69 °C;
[α]D24 = −145.3° (c = 0.06, CHCl3); IR (ATR) 1742, 1706 cm−1; 1H
NMR (600 MHz) for a major rotamer δ 0.03 (s, 3H), 0.04 (s, 3H),
0.89 (s, 9H), 1.30 (s, 3H), 1.41 (s, 9H), 1.46 (s, 3H), 3.64 (dd, J =
10.6, 1.8 Hz, 1H), 4.12 (d, J = 10.8 Hz, 1H), 4.15 (dd, J = 10.7, 2.2 Hz,
1H), 4.26 (t-like, J = 1.8 Hz, 1H), 4.72 (d, J = 5.9 Hz, 1H), 4.95 (t-like,
J = 6.0 Hz, 1H), 9.29 (d, J = 4.0 Hz, 1H); 1H NMR (600 MHz) for a
minor rotamer δ 0.05 (s, 3H), 0.07 (s, 3H), 0.89 (s, 9H), 1.31 (s, 3H),
1.41 (s, 9H), 1.48 (s, 3H), 3.69 (dd, J = 10.5, 1.8 Hz, 1H), 3.90 (dd, J
= 10.5, 2.0 Hz, 1H), 4.12 (dd, J = 8.4, 5.2 Hz, 1H), 4.20 (dd, J = 7.0,
3.7 Hz, 1H), 4.73 (d, J = 5.1, 1H), 4.92 (t-like, J = 6.0 Hz, 1H), 9.34
(d, J = 3.7 Hz, 1H); 13C NMR (150 MHz) for a major rotamer δ −5.7,
18.1, 24.0, 25.8, 28.1, 62.3, 64.8, 69.0, 81.4, 81.7, 82.3, 112.0, 153.4,
198.9; 13C NMR (150 MHz) for a minor rotamer δ −5.6, 18.1, 24.0,
25.7, 28.4, 63.5, 64.5, 69.0, 80.3, 81.1, 83.2, 112.0, 154.4, 198.4; HRMS
(ESI) calcd for C20H37NO6NaSi 438.228 78, found 438.230 20.
Direct Reduction of the N-Boc Acetal 33. A 1 M solution of
DIBAL in toluene (0.15 mL, 0.15 mmol) was added to a solution of
the N-Boc acetal 33 (0.0237 g, 0.0486 mmol) in dry CH2Cl2 (0.2 mL)
at −50 °C, and the whole mixture was stirred at the same temperature
for 8 h. After further addition of a 1 M solution of DIBAL in toluene
(0.25 mL, 0.25 mmol) at −50 °C, the whole mixture was stirred at rt
for 5.5 h and at 40 °C for 0.5 h and quenched with MeOH (0.5 mL)
and saturated aqueous NH4Cl solution (0.5 mL). After filtration of
insoluble precipitate through Celite, the filtrate was evaporated.
Repeated flash chromatography of the residue (hexane/AcOEt 10/1,
15/1, and 30/1 → 20/1) afforded the prolinal 5 (0.0037 g, 18% (22%
brsm)) and the alcohol 34 (0.0023 g, 11% (14% brsm)) as yellow oils,
respectively, which exist as rotational isomers in ratios of 4/1 for 5 and
of 3/1 for 34, respectively.
AUTHOR INFORMATION
■
Corresponding Author
*E-mail: benti@faculty.chiba-u.jp.
Notes
The authors declare no competing financial interest.
REFERENCES
■
(1) Wardrop, D. J.; Waidyarachchi, S. L. Nat. Prod. Rep. 2010, 27,
1431−1468. Watson, A. A.; Fleet, G. W. J.; Asano, N.; Molyneux, R. J.;
Nash, R. J. Phytochemistry 2001, 56, 265−295. Massiot, G.; Delaude,
C. In The Alkaloids; Brossi, A., Ed.; Academic Press: New York, 1986;
Vol. 27, pp 269−322. Takashima, M.; Sakai, H. Bull. Agr. Chem. Soc.
Jpn. 1960, 24, 652−655.
(2) Brandi, A.; Cardona, F.; Cicchi, S.; Cordero, F. M.; Goti, A.
Chem. Eur. J. 2009, 15, 7808−7821. Ayad, T.; Genissson, Y.; Baltas, M.
Curr. Org. Chem. 2004, 8, 1211−1233. Koumbis, A. E.; Gallos, J. K.
Curr. Org. Chem. 2003, 7, 585−628. Gallos, J. K.; Koumbis, A. E. Curr.
Org. Chem. 2003, 7, 397−425. Yoda, H. Curr. Org. Chem. 2002, 6,
223−243. Cardellina, J. H., II; Marner, F.-J.; Moore, R. E. Science 1979,
204, 193−195.
(3) Welter, A.; Jadot, J.; Dardenne, G.; Marlier, M.; Casimir, J.
Phytochemistry 1976, 15, 747−749.
(4) Lamotte-Brasseur, J.; Dupont, L.; Dideberg, O. Acta Crystallogr.,
Sect. B 1977, B33, 409−412.
(5) Asano, N.; Kuroi, H.; Ikeda, K.; Kizu, H.; Kameda, Y.; Kato, A.;
Adachi, I.; Watson, A. A.; Nash, R. J.; Fleet, G. W. J. Tetrahedron:
Asymmetry 2000, 11, 1−8.
(6) Harris, C. M.; Haris, T. M.; Molyneux, R. J.; Tropea, J. E.; Elbein,
A. D. Tetrahedron Lett. 1989, 30, 5685−5688.
(7) For the most recent synthesis of (+)-DMDP (1), see: Tsou, E.-
L.; Yeh, Y.-T.; Liang, P.-H.; Cheng, W.-C. Tetrahedron 2009, 65, 93−
100.
(8) Trost, B. M.; Horne, D. B.; Wltering, M. J. Chem. Eur. J. 2006, 12,
6607−6620.
(9) Takayama, S.; Martin, R.; Wu, J.; Laslo, K.; Siuzdak, G.; Wong,
C.-H. J. Am. Chem. Soc. 1997, 119, 8146−8151. Hung, R. R.; Straub, J.
A.; Whitesides, G. M. J. Org. Chem. 1991, 56, 3849−3855.
(10) For the most recent synthesis of (+)-hyacinthacine A1 (2), see:
D’Adamio, G.; Goti, A.; Parmeggiani, C.; Moreno-Clavijo, E.; Robina,
I.; Cardona, F. Eur. J. Org. Chem. 2011, 7155−7162.
(11) For the most recent synthesis of (+)-1-epi-australine (3), see: M.
Tang, M.; Pyne, S. G. Tetrahedron 2004, 60, 5759−5767.
(12) Reddy, P. V.; Veyron, A.; Koos, P.; Bayle, A.; Greene, A. E.;
Delair, P. Org. Biomol. Chem. 2008, 6, 1170−1172.
(13) Denmark, S. E.; Cottell, J. J. J. Org. Chem. 2001, 66, 4276−4284.
(14) (a) Hada, K.; Watanabe, T.; Isobe, T.; Ishikawa, T. J. Am. Chem.
Soc. 2001, 123, 7705−7706. (b) Haga, T.; Ishikawa, T. Tetrahedron
2005, 61, 2857−2869. (c) Wannaporn, D.; Ishikawa, T. J. Org. Chem.
2005, 70, 9399−9408. (d) Wannaporn, D.; Ishikawa, T.; Kawahata,
M.; Yamaguchi, K. J. Org. Chem. 2006, 71, 6600−6603. (e) Khanti-
kaew, I.; Takahashi, M.; Kumamoto, T.; Suzuki, N.; Ishikawa, T.
Tetrahedron 2012, 68, 878−882.
(15) Manaka, T.; Nagayama, S.-I.; Wannaporn, D.; Yajima, N.;
Kumamoto, T.; Watanabe, T.; Ishikawa, T.; Kawahata, M.; Yamaguchi,
K. Helv. Chim. Acta 2007, 90, 128−142. Hayashi, Y.; Kumamoto, T.;
Nakanishi, W.; Kawahata, M.; Yamaguchi, K.; Ishikawa, T. Tetrahedron
2010, 66, 3836−3841.
(16) (a) Brock, E. A.; Davies, S. G.; Lee, J. A.; Roberts, P. M.;
Thomson, J. E. Org. Lett. 2011, 13, 1594−1597. (b) Kim, J. H.; Curtis-
Long, M. J.; Seo, W. D.; Ryu, Y. B.; Yang, M. S.; Park, K. H. J. Org.
Chem. 2005, 70, 4082−4087. (c) Kim, J. H.; Long, M. J. C.; Kim, J. Y.;
Park, K. H. Org. Lett. 2004, 6, 2273−2276. (d) Knight, D. W.; Redfern,
A. L.; Gilmore, J. J. Chem. Soc., Perkin Trans. 1 2001, 2874−2883.
(e) Jones, A. D.; Knight, D. W.; Hibbs, D. E. J. Chem. Soc. Perkin Trans.
1 2001, 1182−1203. (f) Lee, W. S.; Jang, K. C.; Kim, J. H.; Park, K. H.
Chem. Commun. 1999, 251−252. (g) Tanaka, H.; Yamazaki, K.;
Takamatsu, T.; Yamazaki, T.; Momose, T. J. Org. Chem. 1999, 55,
ASSOCIATED CONTENT
■
S
* Supporting Information
Figures giving 1H and 13C NMR data for compounds trans- and
cis-8, anti- and syn-9, anti- and syn-10, a mixture of 11 and 12,
13−19, (+)-DMDP (1), a mixture of 22 and 23, 25, 26, 28−
34, and (−)-5 and CIF files giving crystal data fpr 19 and 30.
This material is available free of charge via the Internet at
http://pubs.acs.org.
K
dx.doi.org/10.1021/jo301178b | J. Org. Chem. XXXX, XXX, XXX−XXX

The Journal of Organic Chemistry
Article
3947−3950. (h) Tamaru, Y.; Kawamura, S.-I.; Bando, T.; Tanaka, K.;
Hojo, M.; Yoshida, A.-I. J. Org. Chem. 1988, 53, 5491−5501.
(17) Donohoe, T. J.; Sintim, H. O.; Hollinshead, J. J. Org. Chem.
2005, 70, 7297−7304.
(18) Avi, M.; Gaisberger, R.; Feichtenhofer, S.; Griengl, H.
Tetrahedron 2009, 65, 5418−5426.
(19) Colobert, F.; Tito, A.; Khiar, N.; Denni, D.; Medina, M. A.;
Martin-Lomas, M.; Ruano, J.-L. G.; Solladie, G. J. Org. Chem. 1998, 63,
8918−8921.
(20) Crystallographic data are as follows. 19: M = 253.29,
monoclinic, space group P21, a = 9.6958(6) Å, b = 6.1371(4) Å, c =
10.4129(6) Å, β = 92.5870(10)°, V = 618.98(7) Å3, Z = 2, R1 =
0.0307, wR2 = 0.0763, GOF = 1.505. 30: M = 323.38, orthorhombic,
space group P212121, a = 5.69660(10) Å, b = 15.5167(4) Å, c =
19.3507(5) Å, V = 1710.46(7) Å3, Z = 4, R1 = 0.0311, wR2 = 0.0842,
GOF = 1.056. CCDC-875391 (for 19) and CCDC-875392 (for 30)
contain supplementary crystallographic data for this paper. These data
can be obtained free of charge from the Cambridge Crystallographic
Data Centre via www.ccdc.cam.ac.uk/data_request/cif.
(21) Izquierdo, I.; Plaza, M. T.; Tamayo, J. A. Tetrahedron 2005, 61,
6527−6533.
(22) Isobe, T.; Fukuda, K.; Ishikawa, T. Tetrahedron: Asymmetry
1998, 9, 1729−1735.
L
dx.doi.org/10.1021/jo301178b | J. Org. Chem. XXXX, XXX, XXX−XXX